IL1B and COVID-19: There have been no exact or fixed treatment recommendations for COVID-19 have been issued to date, but recent studies have demonstrated that cytokine blockades that specifically target cytokines, such as interleukin IL-1 and IL-6, offer optimistic therapeutic promise for COVID-19 [46].